WHO criteria for diabetes in pregnancy: a retrospective cohort

Zaccara, Tatiana Assunção; Paganoti, Cristiane F.; Mikami, Fernanda Cristina Ferreira; Francisco, Rossana Pulcineli Vieira; Costa, Rafaela Alkmin da

doi:10.1186/s12884-022-04708-w

Cited by 5 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prolonged PROM means pre-labor rupture of the amniotic sac takes more than 18 hours, which is associated with a 10-fold increased risk of neonatal infection [20]. The criterion for maternal diabetes in this study was maternal blood glucose (GCT) above 140 mg/dL with symptoms such as polyuria and polydipsia [21]. Also, blood pressure criteria for preeclampsia were higher than 140/90 mmHg, proteinuria was above +1 [22].…”

Section: Original Articlementioning

confidence: 87%

Exploring the prognostic significance of β-HCG levels in cervicovaginal secretions and maternal risk factors for early birth

Homood Alharbi,

Abdualrahman Saeed Alshehry,

Ahmed Alsadoun

et al. 2024

Cell Mol Biol (Noisy-le-grand)

View full text Add to dashboard Cite

Preterm birth is one of the leading causes of death in the perinatal period, this study was conducted to investigate the predictive value of β-HCG levels in cervicovaginal secretions and maternal risk factors in preterm delivery. This cross-sectional study was conducted over a six-month period from January 1 to June 30, 2021, in Baghdad hospitals. The data were collected and used from the mothers who went to the hospital for delivery. Demographic information of patients and some risk factors were investigated. Vaginal secretions were sampled with a cotton swab. β-HCG level in weeks 29, 31, 33, and 35 was measured by ELISA method. Data were analyzed with SPSS Ver 25 software and a significance level of less than 0.05 was considered. The mean age of the study participants was 28.29 ± 5.68 years. There was a significant difference in the level of β-HCG between women with full-term delivery and pre-term women in weeks 29, 31, 33, and 35 of pregnancy (P ≤ 0.001). Maternal factors such as age older than 35 years, BMI, history of thyroid disease, blood pressure, premature rupture of the amniotic sac, parity, twin and multiple births, and decreased amniotic fluid volume have been identified as factors affecting preterm delivery. The β-HCG level can also be a helpful marker for preterm birth.

show abstract

Section: Original Articlementioning

confidence: 87%

Exploring the prognostic significance of β-HCG levels in cervicovaginal secretions and maternal risk factors for early birth

Homood Alharbi,

Abdualrahman Saeed Alshehry,

Ahmed Alsadoun

et al. 2024

Cell Mol Biol (Noisy-le-grand)

View full text Add to dashboard Cite

show abstract

“…Around 60% of women with a history of GDM develop type II diabetes mellitus later in life. Each subsequent pregnancy [4,38,[43][44][45].…”

Section: Fetal and Maternal Effectsmentioning

confidence: 99%

Gestational Diabetes Mellitus

Gică,

Huluță

2023

Type 2 Diabetes in 2024 - From Early Suspicion to Effective Management

View full text Add to dashboard Cite

Formally recognized by O’Sullivan and Mahan in 1964, gestational diabetes mellitus (GDM) is defined as any degree of hyperglycaemia recognized for the first time in the pregnancy, including type 2 diabetes mellitus diagnosed during pregnancy, as well as true GDM which develops in pregnancy. GDM is currently the most prevalent medical complication during gestation, affecting approximately 15% of pregnancies worldwide. Important risk factors for GDM include being obese, advanced maternal age and having a family history of diabetes mellitus. Expectant mothers with GDM face the risk of developing gestational hypertension, pre-eclampsia, and necessitating cesarean section for pregnancy termination. Moreover, GDM amplifies the likelihood of complications such as cardiovascular disease, obesity, and abnormal carbohydrate metabolism, consequently increasing the chances of type 2 diabetes (T2D) development in both the mother and the child. Pregnancy itself places stress on the body’s insulin production and utilization, and some women are unable to produce enough insulin to overcome the insulin resistance caused by pregnancy hormones. While gestational diabetes usually resolves after pregnancy, the experience of insulin resistance during pregnancy can unmask an underlying predisposition to insulin resistance, which is a key factor in the development of T2D.

show abstract

Plasma Glycated CD59 and Gestational Diabetes Mellitus: A Systematic Review

Asadi,

Safari‐Faramani,

Aghaz

et al. 2024

Endocrino Diabet & Metabol

View full text Add to dashboard Cite

AimsGestational diabetes mellitus (GDM) is a common complication of pregnancy worldwide. The standard method for screening GDM is the 75 g oral glucose tolerance test (OGTT). However, the OGTT is difficult, time‐consuming and requires fasting, making it an inconvenient test for GDM. Researchers have turned their attention to alternative biomarkers for GDM. This study aimed to systematically investigate the potential of plasma glycated CD59 (pGCD59) as a new biomarker for GDM and its associated adverse pregnancy outcomes.MethodsThe systematic review was performed in the PubMed, ISI Web of Science, Scopus and Google Scholar databases from 1/1/2000 to 4/1/2024, and relevant studies were selected based on the inclusion and exclusion criteria. The quality of the studies was assessed using the Newcastle‐Ottawa scale.ResultsThe study revealed that pGCD59 levels before 20 weeks and during the second trimester of pregnancy have the potential to predict the results of the OGTT and also forecast adverse pregnancy outcomes, such as postpartum glucose intolerance (PP GI), neonatal hypoglycaemia (NH) and having large for gestational age (LGA) infants. The predictive ability of pGCD59 was found to be affected by the GDM status, especially body mass index (BMI).ConclusionsIn conclusion, pGCD59 may be a promising indicator of glucose levels and could serve as a new biomarker for GDM. However, additional studies are needed to establish a reliable reference range and cut‐off value for pGCD59.

show abstract

WHO criteria for diabetes in pregnancy: a retrospective cohort

Cited by 5 publications

References 16 publications

Exploring the prognostic significance of β-HCG levels in cervicovaginal secretions and maternal risk factors for early birth

Exploring the prognostic significance of β-HCG levels in cervicovaginal secretions and maternal risk factors for early birth

Gestational Diabetes Mellitus

Plasma Glycated CD59 and Gestational Diabetes Mellitus: A Systematic Review

Contact Info

Product

Resources

About